Bank of Montreal’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Bank of Montreal’s Portfolio MSAC Stock Details MSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-25,091	Closed	-$253K	–	4458
2022 Q4	$253K	Sell	25,091 -9,123	-27%	-$91K	﹤0.01%	3025
2022 Q3	$339	Buy	34,214 +9,123	+36%	+$89.9K	﹤0.01%	2855
2022 Q2	$246	Hold	25,091	–	–	﹤0.01%	3133
2022 Q1	$246K	Hold	25,091	–	–	﹤0.01%	3318
2021 Q4	$244K	Buy	+25,091	New	+$244K	﹤0.01%	2867

Bank of Montreal's MSAC Position: Q1 2023 in Review

Bank of Montreal sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q1 2023, closing a stake of 25,091 shares — an estimated $253K sold.

Bank of Montreal first reported a position in MSAC in Q4 2021 and held it in 5 quarters. The position peaked at $253K in Q4 2022. 0 funds tracked by Wall St. Rank hold MSAC as of Q1 2023.

Bank of Montreal reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
Bank of Montreal sold 25,091 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q1 2023, an estimated $253K.
Bank of Montreal first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q4 2021 and held it in 5 quarters.
Bank of Montreal's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $253K in Q4 2022.
0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q1 2023.

Based on Bank of Montreal's 13F filing for Q1 2023, filed 13 Jun 2024.